Highfields Capital Management’s Eli Lilly LLY Stock Holding History

Highfields Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-350,000	Closed	-$37.6M	–	36
2018 Q3	$37.6M	Buy	+350,000	New	+$35M	0.7%	32
2015 Q4	–	Sell	-700,000	Closed	-$58.6M	–	82
2015 Q3	$58.6M	Hold	700,000	–	–	0.52%	41
2015 Q2	$58.4M	Hold	700,000	–	–	0.52%	38
2015 Q1	$50.9M	Sell	700,000 -2,008,800	-74%	-$143M	0.45%	36
2014 Q4	$187M	Buy	2,708,800 +1,808,800	+201%	+$122M	1.59%	22
2014 Q3	$58.4M	Sell	900,000 -3,100,000	-78%	-$196M	0.46%	47
2014 Q2	$249M	Buy	+4,000,000	New	+$239M	1.83%	16

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Highfields Capital Management's LLY Position: Q4 2018 in Review

Highfields Capital Management sold out of Eli Lilly (LLY) in Q4 2018, closing a stake of 350,000 shares — an estimated $37.6M sold.

Highfields Capital Management first reported a position in LLY in Q2 2014 and held it in 7 quarters. The position peaked at $249M in Q2 2014. 1,560 funds tracked by Wall St. Rank hold LLY as of Q4 2018.

Highfields Capital Management reported no remaining Eli Lilly position as of Q4 2018 after selling out during the quarter.
Highfields Capital Management sold 350,000 Eli Lilly shares in Q4 2018, an estimated $37.6M.
Highfields Capital Management first reported a position in Eli Lilly in Q2 2014 and held it in 7 quarters.
Highfields Capital Management's Eli Lilly position peaked at $249M in Q2 2014.
1,560 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2018.

Based on Highfields Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.